Pulmonary
  • Asthma
  • COPD
  • Pulmonary
amPulmonary Insights
amPulmonary Insights
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
Resources
  • Subscribe
  • About Us
  • Contact Us
  • Sign In
  • Sign In
  • Asthma
  • COPD
  • Pulmonary
  • Subscribe

Site Map

  1. 2026
  2. September
  3. 03
AstraZeneca, Amgen report success for Tezspire in late-stage esophageal disease trial
Can experimental drug prevent lung cancer?
Scientific abstract encourages physicians to get patients with asthma moving more
Study reveals novel fibrotic cell type
Machine learning could help identify lung cancer patients at risk for COPD
Inhaler overuse directly impacts CVD risk, mortality
Page 1 of 1
Pulmonary
Newsletter for Professionals
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
  1. Privacy Policy
  2. About Us
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
© 2026 Ascend Integrated Media. All rights reserved.